Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Annals of Translational Medicine
|
November 22, 2016
Afatinib plus chemotherapy versus chemotherapy alone after progression on afatinib: new insights on old question?
Priyanka Bhateja, Neelesh Sharma
Therapeutic Advances in Medical Oncology
|
December 1, 2011
In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
Neelesh Sharma, Alex A Adjei
International Journal of Biological Sciences
|
August 29, 2013
Stem cell research: a novel boulevard towards improved bovine mastitis management
Neelesh Sharma, Dong Kee Jeong
Anticancer Research
|
October 15, 2013
Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer
Sabarish Ayyappan, Dhivya Prabhakar, Neelesh Sharma
Expert Review of Anticancer Therapy
|
January 9, 2014
Controversies in the management of stage III non-small-cell lung cancer
Tithi Biswas, Neelesh Sharma, Mitchell Machtay
Investigational New Drugs
|
October 4, 2017
Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer
Priyanka Bhateja, Afshin Dowlati, Neelesh Sharma
Chemico-Biological Interactions
|
December 21, 2004
Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells
Neelesh Sharma, Quanren He, Raghubir P Sharma
Toxicology
|
May 13, 2006
Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2
Neelesh Sharma, Quanren He, Raghubir P Sharma
Toxicology
|
September 15, 2004
Augmented fumonisin B1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines
Neelesh Sharma, Quanren He, Raghubir P Sharma
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 9, 2006
Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver
Quanren He, Hirofumi Suzuki, Neelesh Sharma, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Annals of Translational Medicine
|
November 22, 2016
Afatinib plus chemotherapy versus chemotherapy alone after progression on afatinib: new insights on old question?
Priyanka Bhateja, Neelesh Sharma
Therapeutic Advances in Medical Oncology
|
December 1, 2011
In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
Neelesh Sharma, Alex A Adjei
International Journal of Biological Sciences
|
August 29, 2013
Stem cell research: a novel boulevard towards improved bovine mastitis management
Neelesh Sharma, Dong Kee Jeong
Anticancer Research
|
October 15, 2013
Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer
Sabarish Ayyappan, Dhivya Prabhakar, Neelesh Sharma
Expert Review of Anticancer Therapy
|
January 9, 2014
Controversies in the management of stage III non-small-cell lung cancer
Tithi Biswas, Neelesh Sharma, Mitchell Machtay
Investigational New Drugs
|
October 4, 2017
Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer
Priyanka Bhateja, Afshin Dowlati, Neelesh Sharma
Chemico-Biological Interactions
|
December 21, 2004
Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells
Neelesh Sharma, Quanren He, Raghubir P Sharma
Toxicology
|
May 13, 2006
Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2
Neelesh Sharma, Quanren He, Raghubir P Sharma
Toxicology
|
September 15, 2004
Augmented fumonisin B1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines
Neelesh Sharma, Quanren He, Raghubir P Sharma
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 9, 2006
Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver
Quanren He, Hirofumi Suzuki, Neelesh Sharma, et al.
Page
of 9